Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Fendel

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Malaria Journal|February 7, 2016
Acquired immune responses to three malaria vaccine candidates and their relationship to invasion inhibition in two populations naturally exposed to malariaOtchere Addai-Mensah, Melanie Seidel, Nafiu Amidu, et al.
Frontiers in Immunology|November 17, 2022
The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severitySterre L Siekman, Tamas Pongracz, Wenjun Wang, et al.
Plos One|July 7, 2015
Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate--Tackling the Cocktail ChallengeAlexander Boes, Holger Spiegel, Nadja Voepel, et al.
JCI Insight|May 8, 2024
Immune responses associated with protection induced by chemoattenuated PfSPZ vaccine in malaria-naive EuropeansYoanne D Mouwenda, Simon P Jochems, Vincent Van Unen, et al.
Vaccine|August 11, 2010
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, GabonBenjamin Mordmüller, Katja Szywon, Benedikt Greutelaers, et al.
Scientific Reports|August 3, 2022
Immunological profiles associated with distinct parasitemic states in volunteers undergoing malaria challenge in GabonMikhael D Manurung, Sanne E de Jong, Yvonne Kruize, et al.
Plos One|August 11, 2011
A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African childrenSabine Bélard, Saadou Issifou, Aurore B Hounkpatin, et al.
Malaria Journal|June 17, 2022
Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trialOdilon Nouatin, Javier Ibáñez, Rolf Fendel, et al.
Plos One|April 16, 2011
Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D)Selidji T Agnandji, Rolf Fendel, Michaël Mestré, et al.
Elife|April 28, 2021
Common virulence gene expression in adult first-time infected malaria patients and severe casesJ Stephan Wichers, Gerry Tonkin-Hill, Thorsten Thye, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Malaria Journal|February 7, 2016
Acquired immune responses to three malaria vaccine candidates and their relationship to invasion inhibition in two populations naturally exposed to malariaOtchere Addai-Mensah, Melanie Seidel, Nafiu Amidu, et al.
Frontiers in Immunology|November 17, 2022
The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severitySterre L Siekman, Tamas Pongracz, Wenjun Wang, et al.
Plos One|July 7, 2015
Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate--Tackling the Cocktail ChallengeAlexander Boes, Holger Spiegel, Nadja Voepel, et al.
JCI Insight|May 8, 2024
Immune responses associated with protection induced by chemoattenuated PfSPZ vaccine in malaria-naive EuropeansYoanne D Mouwenda, Simon P Jochems, Vincent Van Unen, et al.
Vaccine|August 11, 2010
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, GabonBenjamin Mordmüller, Katja Szywon, Benedikt Greutelaers, et al.
Scientific Reports|August 3, 2022
Immunological profiles associated with distinct parasitemic states in volunteers undergoing malaria challenge in GabonMikhael D Manurung, Sanne E de Jong, Yvonne Kruize, et al.
Plos One|August 11, 2011
A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African childrenSabine Bélard, Saadou Issifou, Aurore B Hounkpatin, et al.
Malaria Journal|June 17, 2022
Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trialOdilon Nouatin, Javier Ibáñez, Rolf Fendel, et al.
Plos One|April 16, 2011
Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D)Selidji T Agnandji, Rolf Fendel, Michaël Mestré, et al.
Elife|April 28, 2021
Common virulence gene expression in adult first-time infected malaria patients and severe casesJ Stephan Wichers, Gerry Tonkin-Hill, Thorsten Thye, et al.
Pageof 8